Exploration of Drug Science (eISSN: 2836-7677) is a peer-reviewed, open access online journal, covering all this process from the first idea in the laboratory to the drug already in the market. Drug Science is a multi-vector scientific activity with a great impact on society. Thus, apart from the scientific fact, the discovery of a new drug can save many lives or restore or improve social health and wellbeing. The journal considers the following topics:

★ Therapeutics strategies

★ Target discovery and validation

★ Medicinal chemistry

★ Computational chemistry, cheminformatics, and bioinformatics

★ High-throughput synthesis and screening; related technologies

★ Omics

★ Pharmacology

★ Toxicology

★ Preclinical research

★ Chemical entities, biologics, biologic treatments

★ Orphan drugs

★ Vaccines

★ Drug repurposing

★ Drug resistance

★ Drug delivery, including nanotechnologies

★ Clinical phases

★ Industry analysis and market studies

★ Patents and Intellectual property

★ Pharmacoeconomics

Exploration of Drug Science is a bimonthly journal and published in February, April, June, August, October, December. All accepted articles will be published immediately after production. Readers can access the content as quickly as possible, and the paper can be cited immediately.

The journal provides immediate open access to all published content. Everyone can enjoy free and unrestricted use of these published content under the Creative Commons Attribution 4.0 International (CC BY) license. More information can be found at Open Access.

Google Scholar

All the articles of the journal are published under the CC BY license to further facilitate open access and improve the academic exchange among researchers. Under this license, authors retain the copyright and full publishing rights without restrictions, and they agree to make their original works completely available and free to use, copy and redistribute in all formats without permission as long as the authors and the original source are properly cited.

The journal adopts a single-blind peer review. Except for some Editorials released by the Editors, all manuscripts will undergo a strict review to assess their novelty, validity and significance, etc. More information can be found at Peer Review Policy and Peer Review Guidelines. For the whole editorial process, please refer to Editorial Process.

To ensure long-term digital preservation, all the published articles will be archived on Portico platform. Authors are encouraged to deposit their articles in PubMed Central and Europe PubMed Central, or other appropriate funding body's archive.

The journal is owned and published by Open Exploration Publishing.